Search results
New weight loss drugs are coming, and they could burn more fat with fewer side effects
NBC News via Yahoo News· 2 hours agoThe drug combines GLP-1 and glucagon. In a phase 3 study of adults in China who were overweight or...
Novo's Wegovy induces higher weight loss in women than men with same heart condition, study shows
Reuters via Yahoo News· 46 minutes agoNovo Nordisk's popular obesity drug Wegovy helped women with a common heart disease lose more weight...
Obesity drug used in Mounjaro and Zepbound may help treat dangerous sleep apnea
WHO13.com· 2 days agoA popular obesity drug may help treat a dangerous disorder in which people struggle to breathe while they sleep, a new study finds. Tirzepatide, the medication in the weight-loss drug Zepbound and …
Weight loss drug could help treat sleep apnea: Study
WPIX New York City, NY via Yahoo News· 9 hours agoPatients who took the drug had their number of sleep apnea episodes reduced by about half to nearly 60 percent compared to just 10 percent who received a...
Weight loss linked with reduced cancer risk in people with obesity: Study
Investing.com· 2 days agoWeight loss linked with reduced cancer risk in people with obesity: Study
New study suggests ditching BMI for 'roundness'-based system
Fox News· 19 hours agoA recently-published study suggests that a body "roundness" index may be a better measure of health...
Researchers have found a ‘clear genetic trigger for obesity’ that applies to some people | CNN
CNN.com· 3 days agoObesity isn’t just a matter of food and exercise — it may be in your genetic code, according to new...
58% Of Patients Discontinue Use Of Obesity Meds Before Reaching Meaningful Weight Loss, Study Shows
Forbes· 4 days agoThere is high demand for obesity medications known as glucagon-like peptide-1 agonists, or GLP-1s. In conjunction with an appropriate diet and exercise regimen, GLP-1s can ...
...Pharmaceuticals Announces Significant Progress on New Diabetes and Obesity Treatments at the...
The Pendulum· 1 day agoThis randomized, double-blind, placebo-controlled, dose-escalation Phase 1b/2a clinical study evaluated the safety, tolerability, pharmacokinetics and efficacy of GZR18 Injection ...